Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
On September 20, 2024, the Food and Drug Administration approved Bortezomib + Dexamethasone + Isatuximab-irfc + Lenalidomide for adults with newly diagnosed multiple myeloma who are not eligible for autologous stem cell transplant (ASCT).
AACR FDA Approval Alert 09/23/24
…